Skip to main content

Impact of Immunotherapies on CNS Outcomes in People with HIV: Potential Benefits, Challenges and Risks

Agency: National Institutes of Health

Assistance Listings
  • 93.242 -- Mental Health Research Grants

Forecasted opportunityLast Updated: May 13, 2026

Important dates

  • Forecasted post date: August 17, 2026
  • Forecasted application due date: October 22, 2026
  • Forecasted award date: July 1, 2027
  • Forecasted project start date: July 1, 2027
  • Fiscal Year: 2027

Award details

  • Expected project funding: $2,000,000
  • Expected awards: 4

Award min.

Not specified

Award max.

Not specified

  • Funding opportunity number:RFA-MH-27-110
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Grant
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Forecast posted date: March 16, 2026
  • Archive date: Not specified
  • Version: 1

View version history on Grants.gov

Summary

The National Institute of Mental Health (NIMH) intends to publish a notice of funding opportunity (NOFO) to solicit biphasic research applications to evaluate the impact of HIV immunotherapies on central nervous system (CNS) outcomes in people with HIV and to identify mechanisms, benefits, and risks associated with their use in the CNS compartment. The primary goal is to generate evidence that informs whether HIV immunotherapies can safely and effectively target CNS HIV persistence while minimizing neurotoxicity and neuroinflammation. By addressing CNS-specific barriers such as blood brain barrier penetration, compartmentalized viral dynamics, and immune-mediated effects, this NOFO will support the development of strategies that contribute to sustained virologic remission across anatomical compartments and improve long-term neurologic and cognitive outcomes in people with HIV. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Investigators with expertise and insights into the impact of HIV immunotherapies on the CNS and viral reservoirs are strongly encouraged to apply to this new NOFO. This NOFO will utilize the R21/R33 activity code.

Eligibility

Nonprofit

  • Nonprofits non-higher education without 501(c)(3)
  • Other Native American tribal organizations
  • Nonprofits non-higher education with 501(c)(3)

Miscellaneous

  • Other

Education

  • Independent school districts
  • Private institutions of higher education
  • Public and state institutions of higher education

Government

  • Federally recognized Native American tribal governments
  • Special district governments
  • State governments
  • City or township governments
  • County governments
  • Public and Indian housing authorities

Business

  • For-profit organizations other than small businesses
  • Small businesses

Additional information on eligibility

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;

Documents

No documents are currently available.

Agency contact information

Email: NIMH.DAR.inquiries@nih.gov

NIMH.DAR.inquiries@nih.gov

Division of AIDS Research Please contact via email.

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov